By Thomas Kerr, CFA
NYSE:GBLI
READ THE FULL GBLI RESEARCH REPORT
Project Manifest
On January 1, 2025, Global Indemnity (NYSE:GBLI) announced that it had completed an extensive reorganization of its business under the project name Project Manifest. This reorganization is a significant milestone that positions the company for enhanced operational efficiency and growth.
This allows the company to move capital or surpluses in a more efficient, flattened type structure. This compares to the prior structure which was more of a vertical organization that was less efficient.
For now, the reportable segments will remain Penn-America and Non-Core Operations with gross premium growth in Penn-America separated by Wholesale Commercial, InsurTech, Assumed Reinsurance, and Specialty Products.
Valuation and Estimates
GBLI book value per share increased to $49.88 as of September 30, 2024. On September 19, 2024, the Board of Directors approved a dividend of $0.35 per common share which was paid on October 7, 2024. The current dividend yield is approximately 3.92%.
Our 2024 total revenue estimate is adjusted to $447.1 million which includes $381.1 million in Net Earned Premiums and $64.3 million in Investment Income. Our 2024 EPS estimate is adjusted to $3.25. As the consolidated combined expense ratio continues to drift down, we believe EPS can increase to approximately $3.48 in 2025.
Management stated its long-term financial goals which are:
1) Grow the overall business at a rate of 10% or higher,
2) Achieve a combined ratio in the low 90’s,
3) Manage the expense ratio to a competitive level of 36%-37%.
GBLI stock is currently selling at 69.3% of book value based on September 30, 2024 shareholders’ equity. We separate our price target into near-term and long-term objectives. Our near-term target is $50.00 which assumes GBLI stock will trade near book value per share. We maintain our long-term price target of $55.00 per share based on the stock selling at a small premium to future book value per share.
SUBSCRIBE TO ZACKS SMALL CAP RESEARCH to receive our articles and reports emailed directly to you each morning. Please visit our website for additional information on Zacks SCR.
DISCLOSURE: Zacks SCR has received compensation from the issuer directly, from an investment manager, or from an investor relations consulting firm, engaged by the issuer, for providing research coverage for a period of no less than one year. Research articles, as seen here, are part of the service Zacks SCR provides and Zacks SCR receives quarterly payments totaling a maximum fee of up to $40,000 annually for these services provided to or regarding the issuer. Full Disclaimer HERE.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。